{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:52:08Z","timestamp":1774335128148,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,23]]},"DOI":"10.7759\/cureus.105732","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:24:28Z","timestamp":1774326268000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Sodium-Glucose Cotransporter-2 Inhibitors With Atrial High-Rate Episodes in Patients With Cardiac Implantable Electronic Devices"],"prefix":"10.7759","author":[{"given":"Wichid","family":"Thirakraisri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thipsukhon","family":"Sathapanasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pariwat","family":"Pengkaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surachat","family":"Jaroonpipatkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2014.01.004","article-title":"Global burden of atrial fibrillation in developed and developing nations","volume":"9","author":"Chugh SS","year":"2014","unstructured":"Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart. 2014, 9:113-9. 10.1016\/j.gheart.2014.01.004","journal-title":"Glob Heart"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100709","article-title":"Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: a prospective multi-centre study","volume":"32","author":"Suwanwela NC","year":"2021","unstructured":"Suwanwela NC, Chutinet A, Autjimanon H, et al.. Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: a prospective multi-centre study. Int J Cardiol Heart Vasc. 2021, 32:100709. 10.1016\/j.ijcha.2020.100709","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad166","article-title":"The influence of atrial high-rate episodes on stroke and cardiovascular death: an update","volume":"25","author":"Toennis T","year":"2023","unstructured":"Toennis T, Bertaglia E, Brandes A, et al.. The influence of atrial high-rate episodes on stroke and cardiovascular death: an update. Europace. 2023, 25:10.1093\/europace\/euad166","journal-title":"Europace"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euz172","article-title":"Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence","volume":"21","author":"Bertaglia E","year":"2019","unstructured":"Bertaglia E, Blank B, Blomstr\u00f6m-Lundqvist C, et al.. Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. Europace. 2019, 21:1459-67. 10.1093\/europace\/euz172","journal-title":"Europace"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07209-8","article-title":"Atrial high-rate episodes in patients with devices without a history of atrial fibrillation: a systematic review and meta-analysis","volume":"36","author":"Doundoulakis I","year":"2022","unstructured":"Doundoulakis I, Gavriilaki M, Tsiachris D, et al.. Atrial high-rate episodes in patients with devices without a history of atrial fibrillation: a systematic review and meta-analysis. Cardiovasc Drugs Ther. 2022, 36:951-8. 10.1007\/s10557-021-07209-8","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.11.003","article-title":"Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance","volume":"10","author":"Thomas L","year":"2017","unstructured":"Thomas L, Abhayaratna WP. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging. 2017, 10:65-77. 10.1016\/j.jcmg.2016.11.003","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.06.002","article-title":"Atrial electrical remodeling in a canine model of sinus node dysfunction","volume":"146","author":"Li G","year":"2011","unstructured":"Li G, Liu E, Liu T, et al.. Atrial electrical remodeling in a canine model of sinus node dysfunction. Int J Cardiol. 2011, 146:32-6. 10.1016\/j.ijcard.2009.06.002","journal-title":"Int J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.03.045","article-title":"Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover","volume":"52","author":"Kallergis EM","year":"2008","unstructured":"Kallergis EM, Manios EG, Kanoupakis EM, et al.. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. J Am Coll Cardiol. 2008, 52:211-5. 10.1016\/j.jacc.2008.03.045","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo Y","year":"2012","unstructured":"Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012, 60:2263-70. 10.1016\/j.jacc.2012.04.063","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2006.12.040","article-title":"Atrial fibrosis and the mechanisms of atrial fibrillation","volume":"4","author":"Everett TH 4th","year":"2007","unstructured":"Everett TH 4th, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm. 2007, 4:S24-7. 10.1016\/j.hrthm.2006.12.040","journal-title":"Heart Rhythm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy","volume":"114","author":"Chen PS","year":"2014","unstructured":"Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014, 114:1500-15. 10.1161\/CIRCRESAHA.114.303772","journal-title":"Circ Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.12.064","article-title":"Autonomic nervous system dysfunction: JACC focus seminar","volume":"73","author":"Goldberger JJ","year":"2019","unstructured":"Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic nervous system dysfunction: JACC focus seminar. J Am Coll Cardiol. 2019, 73:1189-206. 10.1016\/j.jacc.2018.12.064","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvq357","article-title":"Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation","volume":"89","author":"De Jong AM","year":"2011","unstructured":"De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, Van Gilst WH, Van Gelder IC. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res. 2011, 89:754-65. 10.1093\/cvr\/cvq357","journal-title":"Cardiovasc Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.10.030","article-title":"Left atrial pressure and dominant frequency of atrial fibrillation in humans","volume":"8","author":"Yoshida K","year":"2011","unstructured":"Yoshida K, Ulfarsson M, Oral H, et al.. Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm. 2011, 8:181-7. 10.1016\/j.hrthm.2010.10.030","journal-title":"Heart Rhythm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation","volume":"136","author":"Lau DH","year":"2017","unstructured":"Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017, 136:583-96. 10.1161\/CIRCULATIONAHA.116.023163","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15171","article-title":"Improving heart failure outcomes with sodium-glucose cotransporter 2 inhibitors in different patient groups","volume":"25 Suppl 3","author":"Jhund PS","year":"2023","unstructured":"Jhund PS. Improving heart failure outcomes with sodium-glucose cotransporter 2 inhibitors in different patient groups. Diabetes Obes Metab. 2023, 25 Suppl 3:26-32. 10.1111\/dom.15171","journal-title":"Diabetes Obes Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae054","article-title":"Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation","volume":"26","author":"Fichadiya A","year":"2024","unstructured":"Fichadiya A, Quinn A, Au F, et al.. Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation. Europace. 2024, 26:10.1093\/europace\/euae054","journal-title":"Europace"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.777861","article-title":"Sodium-glucose cotransporter 2 inhibitors mechanisms of action: a review","volume":"8","author":"Fonseca-Correa JI","year":"2021","unstructured":"Fonseca-Correa JI, Correa-Rotter R. Sodium-glucose cotransporter 2 inhibitors mechanisms of action: a review. Front Med (Lausanne). 2021, 8:777861. 10.3389\/fmed.2021.777861","journal-title":"Front Med (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray JJ","year":"2019","unstructured":"McMurray JJ, Solomon SD, Inzucchi SE, et al.. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019, 381:1995-2008. 10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14101996","article-title":"Cardiac sodium\/hydrogen exchanger (NHE11) as a novel potential target for SGLT2i in heart failure: a preliminary study","volume":"14","author":"P\u00e9rez-Carrillo L","year":"2022","unstructured":"P\u00e9rez-Carrillo L, Arag\u00f3n-Herrera A, Gim\u00e9nez-Escamilla I, et al.. Cardiac sodium\/hydrogen exchanger (NHE11) as a novel potential target for SGLT2i in heart failure: a preliminary study. Pharmaceutics. 2022, 14:1996. 10.3390\/pharmaceutics14101996","journal-title":"Pharmaceutics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker TA","year":"2020","unstructured":"Zelniker TA, Bonaca MP, Furtado RH, et al.. Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial. Circulation. 2020, 141:1227-34. 10.1161\/CIRCULATIONAHA.119.044183","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74631-x","article-title":"Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial","volume":"14","author":"Nantsupawat T","year":"2024","unstructured":"Nantsupawat T, Apaijai N, Phrommintikul A, Prasertwitayakij N, Chattipakorn SC, Chattipakorn N, Wongcharoen W. Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial. Sci Rep. 2024, 14:27649. 10.1038\/s41598-024-74631-x","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suae036.215","article-title":"Effect of SGLT2 inhibitors on the arrhythmic burden in heart failure","volume":"26","author":"Vecchi A","year":"2024","unstructured":"Vecchi A, Saccinto G, Bisceglia F, et al.. Effect of SGLT2 inhibitors on the arrhythmic burden in heart failure. Eur Heart J Suppl. 2024, 26:89. 10.1093\/eurheartjsupp\/suae036.215","journal-title":"Eur Heart J Suppl"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal B","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, et al.. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017, 377:644-57. 10.1056\/NEJMoa1611925","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01493-z","article-title":"Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices","volume":"109","author":"Pastori D","year":"2020","unstructured":"Pastori D, Miyazawa K, Li Y, Sz\u00e9kely O, Shahid F, Farcomeni A, Lip GY. Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices. Clin Res Cardiol. 2020, 109:96-102. 10.1007\/s00392-019-01493-z","journal-title":"Clin Res Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip GY","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010, 137:263-72. 10.1378\/chest.09-1584","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/469003-association-of-sodium-glucose-cotransporter-2-inhibitors-with-atrial-high-rate-episodes-in-patients-with-cardiac-implantable-electronic-devices","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:24:31Z","timestamp":1774326271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/469003-association-of-sodium-glucose-cotransporter-2-inhibitors-with-atrial-high-rate-episodes-in-patients-with-cardiac-implantable-electronic-devices"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.105732","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}